Johnson & Johnson to stop selling opioids in US
Johnson & Johnson, one of the pharmaceutical giants accused of fueling the deadly opioid crisis in the United States, will stop making or selling the drugs in the US under a $230 million settlement with New York state.
The agreement allows Johnson & Johnson to resolve litigation over its role in the epidemic, which has killed more than half a million people since 1999, according to a statement from New York attorney general Letitia James.
For its part, J&J announced in a separate statement that the settlement allowed it to avoid a trial that was scheduled to begin Monday.
Comments